Related Experiment Video
Updated: Aug 9, 2025

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
Liver and Biliary Tract Disease in Patients with Coronavirus disease-2019 Infection
Sirina Ekpanyapong1, K Rajender Reddy2
1Division of Gastroenterology and Hepatology, Department of Medicine, Huachiew General Hospital, 665 Bumroongmueang Road, Khlong Mahanak, Bangkok 10100, Thailand; Division of Gastroenterology and Hepatology, Department of Medicine, University of Pennsylvania, 2 Dulles, Liver Transplant Office, HUP3400 Spruce Street, Philadelphia, PA 19104, USA.
Insights
Patients with chronic liver disease, including transplant recipients, should get vaccinated against COVID-19. Vaccination reduces infection, hospitalization, and death from coronavirus disease 2019.
Area of Science:
- Hepatology
- Infectious Diseases
- Immunology
Background:
- Coronavirus disease 2019 (COVID-19) is a global pandemic.
- Hepatic abnormalities occur in up to 50% of COVID-19 patients, potentially linked to disease severity.
- The precise mechanisms of liver injury in COVID-19 are multifactorial.
Purpose of the Study:
- To summarize current guidelines for managing chronic liver disease patients during the COVID-19 pandemic.
- To emphasize the importance of SARS-CoV-2 vaccination for individuals with chronic liver disease and cirrhosis.
Main Methods:
- Review of updated clinical management guidelines.
- Analysis of the benefits of SARS-CoV-2 vaccination in the context of chronic liver disease.
Main Results:
- COVID-19 can present with significant hepatic involvement.
- Vaccination against SARS-CoV-2 is strongly recommended for patients with chronic liver disease and cirrhosis.
- Vaccination is associated with reduced rates of COVID-19 infection, hospitalization, and mortality in this population.
Conclusions:
- Patients with chronic liver disease, including liver transplant candidates and recipients, benefit significantly from SARS-CoV-2 vaccination.
- Vaccination is a critical strategy to mitigate COVID-19-related risks in individuals with pre-existing liver conditions.
Abstract:
Coronavirus disease-2019 (COVID-19) had become a global pandemic since March 2020. Although, the most common presentation is of pulmonary involvement, hepatic abnormalities can be encountered in up to 50% of infected individuals, which may be associated with disease severity, and the mechanism of liver injury is thought to be multifactorial. Guidelines for management in patients with chronic liver disease during COVID-19 era are being regularly updated. Patients with chronic liver disease and cirrhosis, including liver transplant candidates and liver transplant recipients are strongly recommended to receive SARS-CoV-2 vaccination because it can reduce rate of COVID-19 infection, COVID-19-related hospitalization, and mortality.
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Pancreatitis II: Collaborative Care
Assessment:
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...

